Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women

This publication has 28 references indexed in Scilit:

• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
  British Journal of Cancer, 2006
• Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention
  JNCI Journal of the National Cancer Institute, 2006
• Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18
  Clinical and Vaccine Immunology, 2005
• Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine
  Vaccine, 2005
• Against which human papillomavirus types shall we vaccinate and screen? the international perspective
  International Journal of Cancer, 2004
• Comparison of Ophthalmic Sponges for Measurements of Immune Markers from Cervical Secretions
  Clinical and Vaccine Immunology, 2004
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay
  Clinical and Vaccine Immunology, 2003
• Evaluation of Seroreactivity to Human Papillomavirus Type 16 Virus-like Particles in an Incident Case-Control Study of Cervical Neoplasia
  The Journal of Infectious Diseases, 1995
• Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
  JNCI Journal of the National Cancer Institute, 1995